Abstract:
Disclosed are specific markers for synovial tissue degradation and methods of using the markers in diagnosing, monitoring or determining a prognosis of synovial disease.
Abstract:
An automatic spectrophotometric absorption analyzer for continuous determination of a plurality of components of a fluid sample, comprising a monochromator with a diffraction grating receiving the light transmitted by a vessel with transparent faces which contains said sample, a photoelectric converter so arranged that the light beam emerging from the monochromator falls on its sensitive element, a unit for determining cyclically a plurality of stop positions of said diffraction grating which define wavelengths corresponding to the absorption lines of components of said sample, and means for automatic computation of the concentration of said components from the signal which is delivered by the converter.
Abstract:
A method for the assessment of bone fragility and osteoporosis fracture risk characterized by:measuring in vitro the concentration of under-carboxylated osteocalcin in a biological fluid sample such as serum, plasma or urine;comparing the concentration of under-carboxylated osteocalcin in the test sample with the concentration in a control sample containing levels of under-carboxylated osteocalcin representative of the upper limit of the normal range, concentrations above this upper limit being indicative of increased risk of bone fracture.